Evidence map›Paper›PMID 33496845›Full record

ArticleHuman genetics2021

A biallelic variant in CLRN2 causes non-syndromic hearing loss in humans.

Barbara Vona, Neda Mazaheri, Sheng-Jia Lin, Lucy A Dunbar, Reza Maroofian, Hela Azaiez, Kevin T Booth, Sandrine Vitry, Aboulfazl Rad, Franz Rüschendorf and 16 more

Open access · hybridAbstract read
In one paragraph

Article in Human genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Clarin-2 gene supplementation durably preserves hearing in a model of progressive hearing loss.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  11. Article
  12. medRxiv : the preprint server for health sciences · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. ARNSHL gene identification: past, present and future.Molecular genetics and genomics : MGG · 2022
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 12 institutions in 5 countries.

Barbara VonaInstitute of Human Genetics, Julius Maximilians University Würzburg, Würzburg, Germany. barbara.vona@uni-wuerzburg.de.ORCID http://orcid.org/0000-0002-6719-3447
Neda Mazaheri *Department of Genetics, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran.ORCID http://orcid.org/0000-0002-7638-5555
Sheng-Jia Lin *Genes & Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.ORCID http://orcid.org/0000-0002-7559-6529
Lucy A Dunbar *Mammalian Genetics Unit, MRC Harwell Institute, Harwell Campus, Didcot, OX11 0RD, UK.ORCID http://orcid.org/0000-0003-2129-9091
Reza MaroofianDepartment of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
Hela AzaiezMolecular Otolaryngology and Renal Research Laboratories, Department of Otolaryngology and Interdisciplinary Graduate Program in Molecular Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.ORCID http://orcid.org/0000-0002-2863-6970
Kevin T BoothMolecular Otolaryngology and Renal Research Laboratories, Department of Otolaryngology and Interdisciplinary Graduate Program in Molecular Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.ORCID http://orcid.org/0000-0003-3061-3652
Sandrine VitryUnit Progressive Sensory Disorders, Pathophysiology and Therapy Institut Pasteur, Institut de L'Audition, INSERM-UMRS1120, Sorbonne Université, 63 rue de Charenton, 75012, Paris, France.ORCID http://orcid.org/0000-0003-4693-7694
Aboulfazl RadDepartment of Otolaryngology-Head and Neck Surgery, Tübingen Hearing Research Centre, Eberhard Karls University Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0001-8627-8828
Franz RüschendorfMax Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany.ORCID http://orcid.org/0000-0001-5640-810X
Pratishtha VarshneyGenes & Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.ORCID http://orcid.org/0000-0002-2619-7775
Ben FowlerImaging & Histology Core, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Christian BeetzCentogene AG, Rostock, Germany.ORCID http://orcid.org/0000-0001-7061-2895
Kumar N AlagramamDepartment of Otolaryngology, School of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH, 44106, USA.
David MurphyDepartment of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.ORCID http://orcid.org/0000-0002-3771-3800
Gholamreza ShariatiDepartment of Medical Genetics, Faculty of Medicine, Ahvaz Jundishapur, University of Medical Sciences, Ahvaz, Iran.
Alireza SedaghatDiabetes Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Henry HouldenDepartment of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.ORCID http://orcid.org/0000-0002-2866-7777
Cassidy PetreeGenes & Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.ORCID http://orcid.org/0000-0002-9379-2400
Shruthi VijayKumarGenes & Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.ORCID http://orcid.org/0000-0001-6679-1261
Richard J H SmithMolecular Otolaryngology and Renal Research Laboratories, Department of Otolaryngology and Interdisciplinary Graduate Program in Molecular Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.ORCID http://orcid.org/0000-0003-1201-6731
Thomas HaafInstitute of Human Genetics, Julius Maximilians University Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0002-0737-0763
Aziz El-AmraouiUnit Progressive Sensory Disorders, Pathophysiology and Therapy Institut Pasteur, Institut de L'Audition, INSERM-UMRS1120, Sorbonne Université, 63 rue de Charenton, 75012, Paris, France.ORCID http://orcid.org/0000-0003-2692-4984
Michael R BowlMammalian Genetics Unit, MRC Harwell Institute, Harwell Campus, Didcot, OX11 0RD, UK. m.bowl@har.mrc.ac.uk.ORCID http://orcid.org/0000-0001-7971-445X
Gaurav K VarshneyGenes & Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.ORCID http://orcid.org/0000-0002-0429-1904
Hamid GalehdariDepartment of Genetics, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
Oklahoma Medical Research Foundation · USNational Hospital for Neurology and Neurosurgery · GBUniversity of Iowa · USAhvaz Jundishapur University of Medical Sciences · IRInserm · FRMary Lyon Centre at MRC Harwell · GBShahid Chamran University of Ahvaz · IRUniversity of Würzburg · DECentogene (Germany) · DEMax Delbrück Center · DEUniversity Hospitals of Cleveland · USUniversity of Tübingen · DE

Funding

Understanding connective tissue development and disease with PDGFR-driven..... P20GM103636 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI THOMPSON, LINDA F · 2013 to 2023
$26.9M
NONSYNDROMIC HEARING LOSS--A COLLABORATIVE STUDYR01DC002842 · NIDCD · UNIVERSITY OF IOWA · PI SMITH, RICHARD J.H. · 1996 to 2024
$12.7M
TRAINING GRANT IN GENETICST32GM007748 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Anne O'Donnell-Luria, Louise Wilkins-Haug · 1985 to 2026
$12.0M
Optimizing Genetic Testing for Deafness for Clinical DiagnosticsR01DC012049 · NIDCD · UNIVERSITY OF IOWA · PI TERRY A BRAUN, Thomas L. Casavant · 2011 to 2026
$8.7M
ANR light4deaf ANR-15-RHUS-0001HearInNoise ANR-17-CE16-0017Medical Research Council 1774724Medical Research Council MC_UP_1503/2Medizinischen Fakultät, Eberhard Karls Universität Tübingen 2545-1-0NIDCD NIH HHS DC002842NIDCD NIH HHS DC012049NIDCD NIH HHS R01 DC002842NIDCD NIH HHS R01 DC012049NIGMS NIH HHS P20 GM103636NIGMS NIH HHS T32 GM007748NIH HHS GM007748NIH HHS GM103636 (Project 3)
6 · The paper itself

Abstract

Deafness, the most frequent sensory deficit in humans, is extremely heterogeneous with hundreds of genes involved. Clinical and genetic analyses of an extended consanguineous family with pre-lingual, moderate-to-profound autosomal recessive sensorineural hearing loss, allowed us to identify CLRN2, encoding a tetraspan protein, as a new deafness gene. Homozygosity mapping followed by exome sequencing identified a 14.96 Mb locus on chromosome 4p15.32p15.1 containing a likely pathogenic missense variant in CLRN2 (c.494C > A, NM_001079827.2) segregating with the disease. Using in vitro RNA splicing analysis, we show that the CLRN2 c.494C > A variant leads to two events: (1) the substitution of a highly conserved threonine (uncharged amino acid) to lysine (charged amino acid) at position 165, p.(Thr165Lys), and (2) aberrant splicing, with the retention of intron 2 resulting in a stop codon after 26 additional amino acids, p.(Gly146Lysfs*26). Expression studies and phenotyping of newly produced zebrafish and mouse models deficient for clarin 2 further confirm that clarin 2, expressed in the inner ear hair cells, is essential for normal organization and maintenance of the auditory hair bundles, and for hearing function. Together, our findings identify CLRN2 as a new deafness gene, which will impact future diagnosis and treatment for deaf patients.

Indexed as

Amino Acid SubstitutionPoint MutationAdultAllelesAnimalsBase SequenceChromosome MappingChromosomes, Human, Pair 4ConsanguinityExome SequencingFemaleGene ExpressionGenes, RecessiveHair Cells, Auditory, InnerHearing Loss, SensorineuralHumansCLRN2 protein, humanMembrane ProteinsTetraspanins

Identifiers

PMID33496845
PMCPMC8099798
OpenAlexW3125732001

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.